Your browser doesn't support javascript.
loading
DNA methylation episignature in Gabriele-de Vries syndrome.
Cherik, Florian; Reilly, Jack; Kerkhof, Jennifer; Levy, Michael; McConkey, Haley; Barat-Houari, Mouna; Butler, Kameryn M; Coubes, Christine; Lee, Jennifer A; Le Guyader, Gwenael; Louie, Raymond J; Patterson, Wesley G; Tedder, Matthew L; Bak, Mads; Hammer, Trine Bjørg; Craigen, William; Démurger, Florence; Dubourg, Christèle; Fradin, Mélanie; Franciskovich, Rachel; Frengen, Eirik; Friedman, Jennifer; Palares, Nathalie Ruiz; Iascone, Maria; Misceo, Doriana; Monin, Pauline; Odent, Sylvie; Philippe, Christophe; Rouxel, Flavien; Saletti, Veronica; Strømme, Petter; Thulin, Perla Cassayre; Sadikovic, Bekim; Genevieve, David.
Afiliação
  • Cherik F; Department of Medical Genetics, Reference Centre for Rare Diseases, Developmental Anomalies and Malformation Syndromes Sud-Est, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
  • Reilly J; Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.
  • Kerkhof J; Molecular Diagnostics Program and Verspeeten Clinical Genome Centre, London Health Sciences and Saint Joseph's Healthcare, London, Ontario, Canada.
  • Levy M; Molecular Diagnostics Program and Verspeeten Clinical Genome Centre, London Health Sciences and Saint Joseph's Healthcare, London, Ontario, Canada.
  • McConkey H; Molecular Diagnostics Program and Verspeeten Clinical Genome Centre, London Health Sciences and Saint Joseph's Healthcare, London, Ontario, Canada.
  • Barat-Houari M; Autoinflammatory and Rare Diseases Unit, Medical Genetic Department for Rare Diseases and Personalized Medicine, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
  • Butler KM; Greenwood Genetic Center, JC Self Research Institute of Human Genetics, Greenwood, SC.
  • Coubes C; Medical Genetic Department for Rare Diseases and Personalized Medicine, Montpellier University Hospital, Montpellier, France.
  • Lee JA; Greenwood Genetic Center, JC Self Research Institute of Human Genetics, Greenwood, SC.
  • Le Guyader G; Clinical Genetics Department, Poitiers University Hospital, Poitiers, France.
  • Louie RJ; Greenwood Genetic Center, JC Self Research Institute of Human Genetics, Greenwood, SC.
  • Patterson WG; Greenwood Genetic Center, JC Self Research Institute of Human Genetics, Greenwood, SC.
  • Tedder ML; Greenwood Genetic Center, JC Self Research Institute of Human Genetics, Greenwood, SC.
  • Bak M; Clinical genetic department, Righospitalet, Copenhagen, Denmark.
  • Hammer TB; Clinical genetic department, Righospitalet, Copenhagen, Denmark; Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Centre, Dianalund, Denmark.
  • Craigen W; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
  • Démurger F; Medical Genetics Department, Bretagne-Atlantique Hospital, Vannes, France.
  • Dubourg C; Department of Molecular Genetics and Genomics, Rennes University Hospital, Rennes, France; Univ Rennes, CNRS, IGDR, UMR 6290, Rennes, France.
  • Fradin M; Department of Clinical Genetics, Reference Centre for Rare Diseases, CLAD Ouest, Rennes University Hospital, Rennes, France.
  • Franciskovich R; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Texas Children's Hospital, Houston, TX.
  • Frengen E; Department of Medical Genetics, Oslo University Hospitals and University of Oslo, Oslo, Norway.
  • Friedman J; Departments of Neurosciences and Pediatrics, University of California San Diego, San Diego, CA; Division of Neurology, Rady Children's Hospital, San Diego, CA; Rady Children's Institute for Genomic Medicine, Rady Children's Hospital, San Diego, CA.
  • Palares NR; Autoinflammatory and Rare Diseases Unit, Medical Genetic Department for Rare Diseases and Personalized Medicine, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
  • Iascone M; Medical Genetics Laboratory, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Misceo D; Department of Medical Genetics, Oslo University Hospitals and University of Oslo, Oslo, Norway.
  • Monin P; Department of Medical Genetics, Women Mother Children Hospital, Hospices Civils de Lyon, Lyon, France.
  • Odent S; Department of Medical Genetics, Reference Center for Developmental Anomalies, CLAD Ouest, Rennes University Hospital, ERN ITHACA, CNRS UMR 6290, Genetics and Development Institute, Rennes University, Rennes, France.
  • Philippe C; Functional Unit of Innovative Diagnosis for Rare Diseases, Dijon Bourgogne University Hospital, Dijon, France.
  • Rouxel F; Medical Genetic Department for Rare Diseases and Personalized Medicine, Montpellier University Hospital, Montpellier, France.
  • Saletti V; Developmental Neurology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Strømme P; Division of Pediatric and Adolescent Medicine, Oslo University Hospital, and University of Oslo, Oslo, Norway.
  • Thulin PC; Department of Neurology, University of Utah, Salt Lake City, UT.
  • Sadikovic B; Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada; Molecular Diagnostics Program and Verspeeten Clinical Genome Centre, London Health Sciences and Saint Joseph's Healthcare, London, Ontario, Canada. Electronic address: bekim.sadikovic@lhsc.on.ca.
  • Genevieve D; Medical Genetic Department for Rare Diseases and Personalized Medicine, Montpellier University Hospital, Montpellier, France. Electronic address: d-genevieve@chu-montpellier.fr.
Genet Med ; 24(4): 905-914, 2022 04.
Article em En | MEDLINE | ID: mdl-35027293
ABSTRACT

PURPOSE:

Gabriele-de Vries syndrome (GADEVS) is a rare genetic disorder characterized by developmental delay and/or intellectual disability, hypotonia, feeding difficulties, and distinct facial features. To refine the phenotype and to better understand the molecular basis of the syndrome, we analyzed clinical data and performed genome-wide DNA methylation analysis of a series of individuals carrying a YY1 variant.

METHODS:

Clinical data were collected for 13 individuals not yet reported through an international call for collaboration. DNA was collected for 11 of these individuals and 2 previously reported individuals in an attempt to delineate a specific DNA methylation signature in GADEVS.

RESULTS:

Phenotype in most individuals overlapped with the previously described features. We described 1 individual with atypical phenotype, heterozygous for a missense variant in a domain usually not involved in individuals with YY1 pathogenic missense variations. We also described a specific peripheral blood DNA methylation profile associated with YY1 variants.

CONCLUSION:

We reported a distinct DNA methylation episignature in GADEVS. We expanded the clinical profile of GADEVS to include thin/sparse hair and cryptorchidism. We also highlighted the utility of DNA methylation episignature analysis for classification of variants of unknown clinical significance.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos do Neurodesenvolvimento / Deficiência Intelectual Limite: Humans / Male Idioma: En Revista: Genet Med Assunto da revista: GENETICA MEDICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos do Neurodesenvolvimento / Deficiência Intelectual Limite: Humans / Male Idioma: En Revista: Genet Med Assunto da revista: GENETICA MEDICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França